These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23587618)

  • 1. [Genic and cellular therapy for peripheral arterial diseases].
    Smadja D; Silvestre JS; Lévy BI
    Transfus Clin Biol; 2013 May; 20(2):211-20. PubMed ID: 23587618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Novel therapies of non-revascularizing peripheral arterial occlusive disease: therapeutic angiogenesis].
    Lara-Hernández R; Lozano-Vilardell P; Cordobés-Gual J
    Med Clin (Barc); 2008 Nov; 131(17):665-9. PubMed ID: 19087795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials.
    Lakshmanan R; Ukani G; Rishi MT; Maulik N
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1125-1140. PubMed ID: 28407473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell therapy of critical limb ischemia in diabetic patients - State of art.
    Dubský M; Jirkovská A; Bem R; Nemcová A; Fejfarová V; Jude EB
    Diabetes Res Clin Pract; 2017 Apr; 126():263-271. PubMed ID: 28288436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Netrin-1 with stem cells promote angiogenesis in limb ischemic rats.
    Chen T; Chen D; Li F; Tan Z
    J Surg Res; 2014 Dec; 192(2):664-9. PubMed ID: 25240286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interventional treament of peripheral arterial disease and diabetic angiopathy].
    Werth S; Halbritter K; Mahlmann A; Weiss N
    Dtsch Med Wochenschr; 2011 Oct; 136(40):1994-7. PubMed ID: 21960325
    [No Abstract]   [Full Text] [Related]  

  • 7. Mesenchymoangioblast-derived mesenchymal stromal cells inhibit cell damage, tissue damage and improve peripheral blood flow following hindlimb ischemic injury in mice.
    Koch JM; D'Souza SS; Schwahn DJ; Dixon I; Hacker TA
    Cytotherapy; 2016 Feb; 18(2):219-28. PubMed ID: 26740280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Classification and strategy of treatment in diabetic angiopathies of the lower limbs].
    Ivashchenko VV; Koval'chuk VS; Ezhelev VF
    Klin Khir; 1995; (7-8):13-5. PubMed ID: 8624918
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of critical limb ischemia.
    Woelk CJ
    Can Fam Physician; 2012 Sep; 58(9):960-3. PubMed ID: 22972725
    [No Abstract]   [Full Text] [Related]  

  • 10. Human Umbilical Cord-Derived Mesenchymal Stem Cells Relieve Hind Limb Ischemia by Promoting Angiogenesis in Mice.
    Wang Z; Zheng L; Lian C; Qi Y; Li W; Wang S
    Stem Cells Dev; 2019 Oct; 28(20):1384-1397. PubMed ID: 31407635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of pluripotent stem cells for vascular therapy.
    Volz KS; Miljan E; Khoo A; Cooke JP
    Vascul Pharmacol; 2012; 56(5-6):288-96. PubMed ID: 22387745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies.
    Qadura M; Terenzi DC; Verma S; Al-Omran M; Hess DA
    Stem Cells; 2018 Feb; 36(2):161-171. PubMed ID: 29226477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic angiogenesis for peripheral artery disease: stem cell therapy.
    Lachmann N; Nikol S
    Vasa; 2007 Nov; 36(4):241-51. PubMed ID: 18357916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower limb ischaemia in patients with diabetic foot ulcers and gangrene: recognition, anatomic patterns and revascularization strategies.
    Mills JL
    Diabetes Metab Res Rev; 2016 Jan; 32 Suppl 1():239-45. PubMed ID: 26455728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current state of stem cell therapy for peripheral artery disease.
    Gupta NK; Armstrong EJ; Parikh SA
    Curr Cardiol Rep; 2014 Feb; 16(2):447. PubMed ID: 24414120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Directions in Therapeutic Angiogenesis and Arteriogenesis in Peripheral Arterial Disease.
    Annex BH; Cooke JP
    Circ Res; 2021 Jun; 128(12):1944-1957. PubMed ID: 34110899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coadministration of endothelial and smooth muscle cells derived from human induced pluripotent stem cells as a therapy for critical limb ischemia.
    Park JJ; Kwon YW; Kim JW; Park GT; Yoon JW; Kim YS; Kim DS; Kwon SM; Bae SS; Ko K; Kim CS; Kim JH
    Stem Cells Transl Med; 2021 Mar; 10(3):414-426. PubMed ID: 33174379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical treatment of critical leg ischemia: current status and future perspectives of gene and cell therapy].
    Emmerich J; Fiessinger JN
    Bull Acad Natl Med; 2006 Mar; 190(3):667-80; discussion 680-1, 683-4. PubMed ID: 17140102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel potential therapy for vascular diseases: blood-derived stem/progenitor cells specifically activated by dendritic cells.
    Porat Y; Assa-Kunik E; Belkin M; Krakovsky M; Lamensdorf I; Duvdevani R; Sivak G; Niven MJ; Bulvik S
    Diabetes Metab Res Rev; 2014 Oct; 30(7):623-34. PubMed ID: 24638886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial progenitor cells derived from Wharton's jelly of the umbilical cord reduces ischemia-induced hind limb injury in diabetic mice by inducing HIF-1α/IL-8 expression.
    Shen WC; Liang CJ; Wu VC; Wang SH; Young GH; Lai IR; Chien CL; Wang SM; Wu KD; Chen YL
    Stem Cells Dev; 2013 May; 22(9):1408-18. PubMed ID: 23252631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.